The COVID-19 pandemic has caused an unprecedented change in the way we work. As global lockdown measures begin to lift, the question of what the ‘new normal’ will look like is at the forefront of employers’ and employees’ minds. As part of the WorkLife 2.0 series, we will explore the future working landscape, and the challenges and opportunities it presents, through a series of blog posts, briefings and podcasts.
In this session, speakers Timothy Wilkins, Holly Insley, Karin Buzanich-Sommeregger and Oliver Dudok van Heel discuss changing attitudes to working from home, and the challenges employers and employees may face when returning to the workplace.
Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie
Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia
Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments
Tax Matters: Trends in tax disputes – what should businesses be aware of?
Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know
Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement
Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?
How secondaries have become primary to GPs and LPs
From chaos to control: making the case for legal project managers
Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends
Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges
MedTech Across Borders – Recent Developments in Japan and the US
MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more
Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways
Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia
Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech
Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?
Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals
Global Perspectives on Health Data Offerings and Considerations for Innovators
Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero
Create your
podcast in
minutes
It is Free
The Everyday Millionaire
Pure Hustle Podcast
Making Bank
The Ramsey Show
Planet Money